The priority intervention is to prepare for transcutaneous pacing because the client has unstable bradycardia with hypotension and signs of poor perfusion. The priority framework is circulation: restoring an adequate heart rate is needed to improve cardiac output before giving medications for pain or ischemia. Inferior STEMI commonly involves the right coronary artery, which often supplies the AV node; ischemia can cause AV block and severe bradycardia. A key warning sign is bradycardia accompanied by hypotension, altered perfusion, chest discomfort, dyspnea, or shock, which requires urgent treatment rather than observation. The most tempting distractor is nitroglycerin because it is common in STEMI care, but it can worsen hypotension, especially when right ventricular involvement is possible.

The nurse should question the 500 mL normal saline bolus because the client has acute decompensated heart failure with signs of fluid overload and possible impaired oxygenation. Using the ABCs, an intervention that can worsen pulmonary edema and breathing takes priority for clarification. In heart failure, increased ventricular filling pressures cause pulmonary congestion; adding isotonic fluid increases preload and can push more fluid into the lungs. A markedly elevated BNP, crackles, tachycardia, and new confusion are warning signs of hemodynamic stress and possible hypoxemia or decreased cerebral perfusion. The tempting concern is the Foley catheter because of infection risk, but strict output monitoring is appropriate during aggressive diuresis in an acutely unstable heart failure client.

The priority is an immediate neurologic assessment and provider notification because sudden unilateral weakness and slurred speech indicate an acute stroke syndrome. The nurse applies a time-sensitive priority framework: new focal neurologic deficits require rapid evaluation and activation of the stroke pathway before less urgent medication or bleeding-screening actions. Warfarin inhibits vitamin K-dependent clotting factors, and an elevated INR increases the risk for serious bleeding, including intracranial hemorrhage. The key warning sign is that any new focal neurologic deficit in an anticoagulated client is an emergency until proven otherwise. Holding warfarin is likely appropriate later, but it does not address the immediate neurologic threat or initiate diagnostic evaluation.

New runs of polymorphic ventricular tachycardia require immediate follow-up because they may represent torsades de pointes in a client with a markedly prolonged QTc. The priority framework is circulation: a malignant ventricular rhythm can rapidly progress to ventricular fibrillation, loss of pulse, and cardiac arrest. Amiodarone prolongs ventricular repolarization, and a QTc greater than 500 ms is a major warning sign for torsades risk, especially with electrolyte abnormalities or other QT-prolonging medications. The key clinical pearl is that a prolonged QTc becomes an emergency when it is accompanied by ventricular ectopy, syncope, or polymorphic ventricular tachycardia. Stable vital signs, metallic taste, and mild nausea require monitoring or supportive care, but they do not outweigh an evolving lethal dysrhythmia.

The correct finding is increased urine output to 35 mL/hr because it indicates improved renal perfusion from increased cardiac output. This is an evaluate-outcomes question: the nurse must judge whether a vasoactive medication is producing the intended physiologic response. Dopamine has dose-dependent adrenergic effects that can increase myocardial contractility and support blood pressure, but the most meaningful outcome is improved tissue and end-organ perfusion. In adults, urine output of at least 30 mL/hr is a key bedside marker of adequate renal perfusion. The most tempting distractor is an increased heart rate, but tachycardia is a potential adverse effect that can increase myocardial oxygen demand and worsen cardiogenic shock.

The correct action is to hold digoxin, check the digoxin level and potassium, and notify the provider because the findings indicate possible digoxin toxicity. Using the nursing process and NCJMM analyze-cues step, the nurse links gastrointestinal symptoms, yellow visual changes, irregular rhythm, and hypokalemia to a medication toxicity risk. Digoxin inhibits the sodium-potassium ATPase pump; when potassium is low, digoxin has a greater toxic effect at this pump, increasing the risk for dysrhythmias. A key warning sign is the combination of GI symptoms plus visual disturbances in a client taking digoxin, especially if a potassium-wasting diuretic such as furosemide is also prescribed. Giving the next dose is the most dangerous distractor because it ignores toxicity cues and may worsen conduction disturbances.

The correct answer is high-intensity interval training because severe aortic stenosis limits the heart’s ability to increase cardiac output during exertion. This question uses the clinical reasoning principle of risk reduction through patient teaching: the safest instruction is to avoid activities that rapidly increase myocardial oxygen demand. In aortic stenosis, the narrowed valve creates a fixed left ventricular outflow obstruction, so sudden exertion can precipitate syncope, angina, dysrhythmias, or sudden cardiac death. A key clinical pearl is that new or worsening exertional chest pain, dyspnea, or syncope in a client with aortic stenosis requires prompt evaluation. Slow stair climbing may seem concerning, but with pacing and rest it is usually lower intensity than interval training and is not the best activity to avoid.

Ondansetron is the medication the nurse should question because it can prolong the QT interval and increase the risk for torsades de pointes. The clinical judgment task is medication-safety recognition: in a client with long QT syndrome, the nurse must identify drugs that can further delay ventricular repolarization. QT prolongation reflects delayed cardiac repolarization, which can trigger a polymorphic ventricular tachycardia that may deteriorate into ventricular fibrillation. A key warning sign is syncope, palpitations, or new dizziness in a client taking QT-prolonging medications, especially with hypokalemia or hypomagnesemia. Pantoprazole may appear plausible because electrolyte disturbances can contribute to dysrhythmias, but it is not a direct QT-prolonging medication like ondansetron.

The correct finding is hypotension with rising jugular venous pressure and muffled heart sounds, which reflects Beck's triad and supports cardiac tamponade. Using the NCJMM step of analyzing cues, the nurse distinguishes expected pericarditis findings from signs of hemodynamic compromise. In tamponade, fluid accumulates in the pericardial sac, compresses the heart, limits ventricular filling, and reduces stroke volume and cardiac output. The major warning sign is progression from inflammatory findings to obstructive shock, often with tachycardia, hypotension, jugular venous distention, muffled heart sounds, and possible pulsus paradoxus. A pericardial friction rub is a tempting distractor because it is strongly associated with pericarditis, but it does not indicate that cardiac filling is being compromised.

Shortness of breath with pink, frothy sputum is the most concerning finding because it suggests acute pulmonary edema and impaired gas exchange. The priority framework is the ABCs: breathing problems take precedence over stable or minor bleeding findings. Pulmonary edema occurs when elevated pulmonary venous pressure forces fluid into the alveoli, which can produce frothy, blood-tinged sputum and rapidly worsening hypoxemia. In a client with a mechanical mitral valve, this may indicate acute heart failure, prosthetic valve dysfunction, or thrombotic obstruction and requires immediate assessment and escalation of care. The tempting distractors involve anticoagulation, but INR values near 3 may be therapeutic for many mechanical mitral valves, and minor bruising or gum bleeding is less urgent than respiratory compromise.

The correct finding is sudden relief of chest pain with ST segments trending toward baseline, which indicates successful reperfusion after thrombolytic therapy. This question tests evaluate-outcomes: the nurse must determine whether the expected therapeutic effect of alteplase has occurred. Alteplase converts plasminogen to plasmin, which breaks down fibrin in the coronary thrombus and can restore blood flow to ischemic myocardium. As myocardial oxygenation improves, ischemic pain decreases and ECG evidence of injury begins to resolve. The critical safety pearl is that neurologic changes or bleeding after alteplase are complications until proven otherwise. The tempting adverse-effect distractors, such as new confusion or coffee-ground emesis, signal possible hemorrhage rather than medication effectiveness.

The client receiving sotalol with a QTc of 520 ms has the highest risk for developing torsades de pointes. Using the NCJMM step of analyzing cues, the nurse must interpret the QTc value and connect it to a medication known to prolong ventricular repolarization. Sotalol blocks cardiac potassium channels, lengthening phase 3 repolarization and increasing the risk for early afterdepolarizations that can trigger polymorphic ventricular tachycardia. A key warning sign is a QTc greater than 500 ms, especially with QT-prolonging medications, hypokalemia, hypomagnesemia, bradycardia, or renal impairment. The furosemide option is tempting because loop diuretics can lower potassium and magnesium, but the potassium value given is normal and does not show the electrolyte trigger associated with torsades.

The nurse should hold spironolactone and notify the provider because the client has hyperkalemia with impaired renal function while receiving two potassium-raising medications. The clinical reasoning priority is to analyze the cues: potassium 5.8 mEq/L is elevated, creatinine 2.2 mg/dL suggests decreased renal clearance, and both spironolactone and ACE inhibitors can increase serum potassium. Spironolactone blocks aldosterone, reducing potassium excretion, while ACE inhibitors decrease aldosterone production and can compound potassium retention. The major warning sign is that hyperkalemia may cause cardiac conduction disturbances and life-threatening dysrhythmias, even before severe symptoms appear. The tempting distractors involving potassium foods or supplements are wrong because additional potassium intake can worsen the electrolyte imbalance.

The priority action is to notify the provider of a suspected arterial embolus because a sudden cold, pale, pulseless foot indicates acute limb ischemia. Using the priority framework of preserving perfusion and preventing irreversible tissue injury, this finding requires immediate escalation for vascular evaluation and intervention. In infective endocarditis, valve vegetations can detach and travel through the arterial circulation, lodging in a peripheral artery and abruptly blocking blood flow. The key warning signs are the six Ps: pain, pallor, pulselessness, paresthesia, paralysis, and poikilothermia. Elevating the limb is a tempting distractor, but it can further reduce arterial blood flow to the ischemic foot. Heat and delayed reassessment are also unsafe because they do not restore perfusion and may worsen tissue injury or delay limb-saving care.

The correct finding is symptomatic bradycardia with hypotension, which indicates that metoprolol may be excessively reducing cardiac output. Using the nursing process and medication-safety framework, the nurse recognizes the dangerous cue, holds the medication, reassesses perfusion, and notifies the health care provider. Metoprolol is a beta-1 blocker that decreases heart rate, contractility, and myocardial oxygen demand, which is beneficial after myocardial infarction but can cause bradycardia and hypotension. The key warning sign is not the number alone; it is the combination of a low heart rate, low blood pressure, and symptoms such as dizziness, syncope, weakness, or altered mental status. The most tempting distractor is mild asymptomatic bradycardia, which may be tolerated depending on the prescribed parameters and the client’s baseline status.

Reinfarction is most likely because recurrent crushing chest pain, new ST-segment elevation in the same infarct territory, and a renewed troponin rise after a prior decline indicate new myocardial injury. The clinical reasoning is prioritizing hypotheses: the nurse must match the pattern of ECG and biomarker changes to the most likely post-MI complication. Pathophysiologically, recurrent coronary artery occlusion or impaired reperfusion causes additional ischemia and myocardial cell death, releasing more troponin. The key warning sign is a new rise in troponin after it had been falling, because troponin may remain elevated for days after the original MI. Dressler syndrome is a tempting distractor, but it is typically delayed for weeks and causes pericarditis findings rather than focal recurrent ST elevation in the same ischemic leads.

The priority goal is to lower the mean arterial pressure (MAP) by 20% to 25% during the first hour. This applies the clinical judgment principle of choosing a treatment goal that reduces immediate target-organ injury without causing hypoperfusion. In chronic or severe hypertension, cerebral, coronary, and renal autoregulation shifts to tolerate higher pressures; a sudden drop to normal can cause ischemic stroke, myocardial ischemia, or acute kidney injury. IV labetalol is titratable and can reduce blood pressure by decreasing heart rate, contractility, and systemic vascular resistance. A key clinical pearl is that hypertensive emergency treatment is controlled and progressive, not immediate normalization. The tempting choice of reducing blood pressure to less than 120/80 is unsafe because it ignores the risk of organ ischemia from overly rapid pressure reduction.

ST-segment elevation in contiguous leads is the most specific ECG pattern for acute transmural myocardial injury because it indicates injury across the full thickness of the myocardium in a regional coronary distribution. The clinical judgment task is to recognize and analyze a diagnostic cue that signals a time-sensitive STEMI pathway. Acute coronary artery occlusion causes severe ischemia, cellular injury, and altered myocardial electrical repolarization, producing regional ST elevation on the 12-lead ECG. A key clinical pearl is that ST elevation must be assessed in anatomically contiguous leads, not as an isolated single-lead change. The most tempting distractor is ST depression, which is clinically important but more often reflects subendocardial ischemia, NSTEMI/unstable angina, or reciprocal change rather than primary transmural injury.

The nurse should question the prescription for lisinopril because sacubitril/valsartan must not be administered concurrently with an ACE inhibitor. The clinical judgment task is to analyze the medication list for a high-risk drug interaction before administration. Sacubitril inhibits neprilysin, which can increase bradykinin; ACE inhibitors also decrease bradykinin breakdown, greatly increasing the risk for angioedema. A 36-hour washout period is required when switching between an ACE inhibitor and sacubitril/valsartan. The key warning sign is swelling of the face, lips, tongue, or airway, which can rapidly compromise breathing. Spironolactone is a tempting distractor because it can contribute to hyperkalemia, but it is commonly used in heart failure with potassium and renal monitoring rather than being absolutely contraindicated.

The finding that requires delaying elective cardioversion is atrial fibrillation lasting longer than 48 hours without anticoagulation. This question tests recognizing a risk cue: cardioversion may restore atrial contraction and dislodge a thrombus that formed during prolonged atrial stasis. The highest-risk site is the left atrial appendage, and embolization can cause an ischemic stroke or systemic embolism. Current standard management is therapeutic anticoagulation before elective cardioversion for atrial fibrillation lasting more than 48 hours or of unknown duration, unless a TEE excludes atrial thrombus. A normal potassium level supports safety, and therapeutic anticoagulation for several weeks supports proceeding rather than delaying. Tachycardia with stable blood pressure is not a reason to delay; true hemodynamic instability would require urgent cardioversion.

New ventricular bigeminy is the priority finding because it signals ventricular electrical instability during milrinone therapy. Using the clinical judgment process, the nurse must analyze which assessment cue represents an adverse drug effect that can rapidly become life-threatening. Milrinone is an inodilator and phosphodiesterase-3 inhibitor that increases myocardial contractility and causes vasodilation, but it can also increase myocardial irritability and precipitate ventricular dysrhythmias. The key warning sign is any new ventricular rhythm change, which can deteriorate into ventricular tachycardia or ventricular fibrillation. Mild hypotension may occur from vasodilation and warrants monitoring, but it is less urgent than a new ventricular dysrhythmia.

The priority is to notify the provider about suspected digoxin toxicity with hypokalemia because the client has anorexia, an irregular rhythm, and a potassium level of 2.8 mEq/L. Using the nursing process and NCJMM analyze-cues step, the nurse must connect the low potassium and symptoms to a medication toxicity risk before selecting the safest action. Hypokalemia increases myocardial sensitivity to digoxin by enhancing digoxin’s effects at the sodium-potassium ATPase pump, making dysrhythmias more likely even when the digoxin dose or level may otherwise appear acceptable. A key clinical pearl is that early digoxin toxicity often begins with gastrointestinal symptoms, such as anorexia, nausea, or vomiting, before severe cardiac manifestations occur. Giving the next digoxin dose is the most dangerous distractor because it could intensify toxicity and worsen the dysrhythmia.

The best explanation is that bacteria on infected heart valves are difficult to eradicate and require prolonged IV antibiotic therapy. This question primarily tests analyzing cues: the nurse must connect the prescribed duration and route of therapy to the pathophysiology of infective endocarditis. In endocarditis, microorganisms become embedded in valve vegetations composed of fibrin and platelets, which limits immune access and makes antibiotic penetration more difficult. Sustained bactericidal serum levels are needed for weeks to sterilize the vegetation and prevent relapse, embolic events, valve destruction, and heart failure. A key clinical pearl is to monitor for persistent fever, new or worsening murmur, signs of emboli, and heart failure during treatment. The tempting misconception is that IV therapy is used because oral antibiotics never work, but many infections respond to oral therapy; endocarditis is different because of the protected valve vegetation.

The correct finding is heart rate 52 with dizziness or near syncope because it indicates symptomatic bradycardia and possible cerebral hypoperfusion from excessive beta-blockade. Using the NCJMM step of recognize cues, the nurse identifies the assessment finding that signals medication intolerance rather than therapeutic response. Carvedilol blocks beta-adrenergic stimulation, reducing heart rate and myocardial workload; however, an excessively slow rate can reduce cardiac output. A key warning sign is not bradycardia alone, but bradycardia with symptoms such as dizziness, syncope, weakness, or hypotension. The most tempting distractors, such as weight loss or reduced edema, are usually expected improvements from heart failure therapy, especially from furosemide.

The correct finding is sudden cessation of chest tube drainage with rising JVP and hypotension because it is highly suspicious for cardiac tamponade. The clinical reasoning priority is circulation: obstructed drainage after CABG can allow blood to collect around the heart, limiting ventricular filling and rapidly decreasing cardiac output. Tamponade may present with hypotension, jugular venous distention, muffled heart sounds, tachycardia, narrowing pulse pressure, and abrupt changes in chest tube output. A key warning sign is that less drainage is not always improvement; a sudden stop in output can mean the tube is blocked. Chest tube output of 70 mL/hr may be acceptable early after surgery if stable and trending appropriately, making it less urgent than signs of obstructive shock.

The nurse should question ivabradine when the client has a resting heart rate of 56/min in sinus rhythm because the medication further slows sinoatrial node firing and can cause clinically significant bradycardia. The clinical reasoning is medication safety: before administering a rate-lowering drug, the nurse must recognize assessment cues that make administration unsafe. Ivabradine selectively inhibits the cardiac pacemaker current in the sinoatrial node, reducing heart rate without directly decreasing myocardial contractility. A key clinical pearl is that ivabradine is used for selected clients with stable symptomatic heart failure with reduced ejection fraction who are in sinus rhythm and have an elevated resting heart rate despite appropriate therapy. The tempting distractor is the low ejection fraction, but reduced ejection fraction is part of the appropriate heart-failure population for ivabradine rather than a reason to question it.

The finding that best indicates effective pericardiocentesis is improved blood pressure with decreased jugular venous distension. This is an evaluate-outcomes question because the nurse must determine whether the intervention relieved the client’s hemodynamic compromise. In cardiac tamponade, fluid accumulates in the pericardial sac, compresses the heart, limits ventricular filling, and reduces stroke volume and cardiac output. Successful drainage reduces intrapericardial pressure, so venous congestion improves and blood pressure rises. A key warning pattern for tamponade is Beck’s triad: hypotension, jugular venous distension, and muffled heart sounds. The most tempting distractors describe continued compromise: pulsus paradoxus, hypotension with tachycardia, and muffled heart sounds should improve, not worsen, after effective drainage.

The priority action is to stop heparin because a platelet count drop of more than 50% during heparin therapy is highly suspicious for heparin-induced thrombocytopenia (HIT). The key clinical judgment step is analyzing cues: the nurse must interpret the falling platelet count as a serious medication-related complication, not as simple bleeding risk. HIT occurs when antibodies form against heparin-platelet factor 4 complexes, causing platelet activation, platelet consumption, and a paradoxical risk for thrombosis. The major warning sign is a significant platelet decline with new or worsening clotting while receiving heparin. Continuing heparin is the most dangerous distractor because it sustains the immune reaction and increases the risk of life-threatening thrombosis.

The correct action is to hold the diuretic and notify the provider because new tinnitus and hearing difficulty suggest loop diuretic–associated ototoxicity. The key clinical judgment step is analyzing cues: the nurse links auditory symptoms with a medication adverse effect and then takes action to prevent further harm. Loop diuretics can alter electrolyte and fluid composition in the inner ear, and risk increases with high doses, rapid IV administration, renal impairment, and concurrent ototoxic medications. The clinical pearl is that tinnitus is an early warning sign; continued exposure can progress to hearing loss that may be irreversible. Reassuring the client is tempting because tinnitus can seem minor, but it is unsafe because it delays medication-safety intervention.

The nurse should assess the post-myocardial infarction client with new chest discomfort and diaphoresis first because these findings suggest active ischemia, infarct extension, or reinfarction. This is a priority-setting question that requires analyzing acuity and instability: new or worsening symptoms take priority over expected or stable findings. During myocardial ischemia, reduced coronary blood flow deprives cardiac tissue of oxygen, triggering chest discomfort and sympathetic signs such as diaphoresis. A key clinical pearl is that new chest pain after myocardial infarction is never routine and requires rapid assessment and escalation. The most tempting distractor is the client with heart failure and weight gain, but fluid retention without dyspnea or acute respiratory compromise is concerning rather than immediately life-threatening.